12:00 AM
May 21, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Midaform Insulin PharmFilm: Phase I data

A double-blind, dose-escalation, Swiss Phase I trial in 27 healthy volunteers showed that Midaform Insulin PharmaFilm was safe. The partners said that the product mimicked the delivery characteristics of monomeric insulin from pancreas, with a...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >